Indoco Remedies Balance Sheet Annual

Trade

BSE: 532612 | NSE: INDOCO | ISIN: INE873D01024 | Sector: Biotechnology & Drugs

321.90 +1.90 (0.59%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash Equivalents	24.33	-	-	-
Short Term Investments	14.20	1.73	0.00	0.00
Cashand Short Term Investments	38.53	11.93	16.77	8.79
Accounts Receivable- Trade Net	406.20	350.94	297.24	233.82
Total Receivables Net	409.45	436.41	322.83	238.09
Total Inventory	353.06	342.79	322.28	258.50
Other Current Assets Total	153.63	5.48	102.19	108.52
Total Current Assets	954.67	808.18	773.62	622.53
Property/ Plant/ Equipment Total- Net	891.09	667.58	584.66	553.53
Goodwill Net	21.52	0.09	0.09	0.09
Intangibles Net	166.49	124.18	91.88	84.51
Long Term Investments	8.18	1.46	0.02	0.02
Note Receivable- Long Term	3.12	49.32	21.16	25.44
Other Long Term Assets Total	99.66	7.38	14.66	28.94
Total Assets	2,144.73	1,658.20	1,486.09	1,315.06
Accounts Payable	153.64	123.46	133.29	113.23
Current Portof LT Debt/ Capital Leases	307.82	54.86	46.09	45.49
Other Currentliabilities Total	150.87	100.40	115.44	130.90
Total Current Liabilities	612.33	424.51	424.85	406.92
Long Term Debt	351.73	143.50	95.88	96.94
Capital Lease Obligations	12.41	15.04	10.96	7.01
Total Long Term Debt	364.14	158.54	106.85	103.94
Total Debt	671.96	331.77	256.67	265.76
Deferred Income Tax	11.83	6.14	10.60	-
Minority Interest	0.60	-	-	-
Other Liabilities Total	45.93	40.76	39.15	35.21
Total Liabilities	1,034.83	629.95	581.45	546.07
Common Stock Total	18.44	18.43	18.43	18.43
Retained Earnings( Accumulated Deficit)	1,091.46	945.61	822.00	686.35
Total Equity	1,109.90	1,028.25	904.64	768.99
Total Liabilities Shareholders' Equity	2,144.73	1,658.20	1,486.09	1,315.06
Total Common Shares Outstanding	9.22	9.22	9.22	9.22
Tangible Book Valueper Share Common Eq	99.99	98.10	88.19	74.27
Cash	-	10.21	16.77	8.79
Prepaid Expenses	-	11.56	9.54	8.63
Property/ Plant/ Equipment Total- Gross	-	1,168.59	1,036.32	960.09
Accumulated Depreciation Total	-	-501.01	-451.66	-406.56
Accrued Expenses	-	27.42	26.30	0.98
Notes Payable/ Short Term Debt	-	118.37	103.73	116.32
Additional Paid- In Capital	-	64.21	64.21	64.21